Neopterin in Acute Coronary Syndrome Patients
NCT05080387 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2022-02-15
Summary
Measurement of neopterin in ACS patients
Conditions
- Neopterin in Acute Coronary Syndrome Patients
Interventions
- OTHER
-
Blood sample
Blood samples will obtained for measurement of neopterin level through ELIZA
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Magdy Ibrahim Aldesowky, Lecturer · Assiut University
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-11-01
- Primary Completion
- 2023-10-01
- Completion
- 2024-10-01
Countries
- Egypt
Study Locations
More Related Trials
-
ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-3 Study
NCT04609111 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Appropriateness of Aspirin Use in Medical Outpatients
NCT03387384 ·Status: UNKNOWN
-
Aspirin Responsiveness in Women With Coronary Artery Disease
NCT01406990 ·Status: COMPLETED
-
Comparison of the VerifyNow® Aspirin Test and PRUTest® Platelet Reactivity Tests With Investigational Reagent to Reagents Registered in Japan
NCT03615846 ·Status: UNKNOWN
-
Anticoagulation for Aortic Bioprosthesis (ANTIPRO)
NCT03807921 ·Status: COMPLETED ·Phase: PHASE4
-
Platelet Aggregation in Diabetic Patients With Acute Coronary Syndrome Treated With Different Doses of Aspirin
NCT05293808 ·Status: COMPLETED ·Phase: PHASE4
-
A Study To Test The Effect Of Apatinib On P450 Enzymes
NCT03245307 ·Status: UNKNOWN ·Phase: PHASE1
-
Long-term Follow-up of antithrombotIc Management Patterns in Acute Coronary Syndrome Patients in Asia-China Extension
NCT02305680 ·Status: COMPLETED
-
Aspirin Responsiveness in Women at Risk for Cardiac Events
NCT00818337 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Artery Conditions of 'At-risk' Asian People Not on Lipid-lowering Drugs
NCT00970918 ·Status: COMPLETED ·Phase: NA
-
Protective Effect of Aspirin on COVID-19 Patients
NCT04365309 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Aspirin Reload Before Percutaneous Coronary Intervention: Reperfusion Indexes Evaluation.
NCT01374698 ·Status: COMPLETED ·Phase: PHASE4
-
Prevention of Cardiovascular Events by Antiplatelet Agents After Acute Coronary Syndrome
NCT01952392 ·Status: COMPLETED
-
Residual Platelet Activity Despite Aspirin Utilization in Coronary Heart Disease
NCT01820429 ·Status: COMPLETED
-
Long-tErm Follow-uP of antithrombotIc Management Patterns In Acute CORonary Syndrome Patients in Asia
NCT01361386 ·Status: COMPLETED
-
Optimal Antithrombotic Therapy for ACS Patients Concomitant With AF and Implanted With New-generation DES (OPTIMA-3, 4)
NCT03234114 ·Status: UNKNOWN ·Phase: PHASE4
-
Aspirin Resistance and Stroke Risk: Platelet Function Analysis in Patients With Ischemic Events
NCT01586975 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Clopidogrel Aspirin Therapy (CAT) Versus Apixiban Aspirin Therapy (AAT) After Lower Limb Revascularization
NCT04168398 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Effects of Preoperative Aspirin on Graft Patency and Cardiac Events in Off-pump Coronary Artery Bypass
NCT01268917 ·Status: UNKNOWN ·Phase: PHASE3
-
Warfarin and Coronary Calcification Project
NCT00868712 ·Status: COMPLETED
-
Effect of Antithrombotic Treatment in Patients With Both Coronary Heart Disease and Atrial Fibrillation
NCT03051061 ·Status: UNKNOWN
-
Comparative Effects of Aspirin and SGLT2 Inhibitors on Liver Enzymes, Lipid Profile, and FibroScan Findings in Non-Alcoholic Fatty Liver Disease
NCT07338331 ·Status: COMPLETED ·Phase: NA
-
Cost Effectiveness Analysis In Patients With Heart Valve Prosthesis
NCT02022527 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Effectiveness of Early Aspirin Administration After Mitral Valve Repair
NCT06738992 ·Status: RECRUITING ·Phase: PHASE4
-
Predictors of Cardiovascular Risk in Covid-19 Patients During Acute Disease and at Short Term Follow-up
NCT04371289 ·Status: COMPLETED